Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341

By Fang Yong   Hu Yi   Wu Peng   Wang Beibei   Tian Yuan   Xia Xi   Zhang Qinghua   Chen Tong   Jiang Xuefeng   Ma Quanfu   Xu Gang   Wang Shixuan   Zhou Jianfeng   Ma Ding   Meng Li  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 247-252

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S 2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients

By Hsieh Yi-Hsuan  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 475-485

Oxford University Press

Access to resources Recommend Favorite

Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines

By        

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 409-420

Spandidos Publications

Access to resources Recommend Favorite

Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells

By Yamanegi Koji   Kawabe Mutsuki   Futani Hiroyuki   Nishiura Hiroshi   Yamada Naoko   Kato-Kogoe Nahoko   Kishimoto Hiromitsu   Yoshiya Shinichi   Nakasho Keiji  

International Journal of Oncology, Vol. 46, Iss. 5, 2015-05 ,pp. : 1994-2002

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite